ArticleOncoTargets and therapy2014

Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.

Leah K O'Shea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.